Phenotypic subgrouping and multi-omics analyses reveal reduced diazepam-binding inhibitor (DBI) protein levels in autism spectrum disorder with severe language impairment

BACKGROUND: The mechanisms underlying autism spectrum disorder (ASD) remain unclear, and clinical biomarkers are not yet available for ASD. Differences in dysregulated proteins in ASD have shown little reproducibility, which is partly due to ASD heterogeneity. Recent studies have demonstrated that s...

Descripción completa

Detalles Bibliográficos
Autores principales: Pichitpunpong, Chatravee, Thongkorn, Surangrat, Kanlayaprasit, Songphon, Yuwattana, Wasana, Plaingam, Waluga, Sangsuthum, Siriporn, Aizat, Wan Mohd, Baharum, Syarul Nataqain, Tencomnao, Tewin, Hu, Valerie Wailin, Sarachana, Tewarit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438570/
https://www.ncbi.nlm.nih.gov/pubmed/30921354
http://dx.doi.org/10.1371/journal.pone.0214198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438570/
https://www.ncbi.nlm.nih.gov/pubmed/30921354
http://dx.doi.org/10.1371/journal.pone.0214198

Ejemplares similares